Taxol and platinum chemotherapy in the treatment of pancreatic and jejunal carcinoma

✍ Scribed by Terri L. Cornelison; Jeffrey M. Goldberg; Dr. M. Steven Piver

• Book ID: 102924334
• Publisher: John Wiley and Sons
• Year: 1995
• Tongue: English
• Weight: 516 KB
• Volume: 59
• Category: Article
• ISSN: 0022-4790
• DOI: 10.1002/jso.2930590314

✦ Synopsis

Pancreatic cancer and jejunal cancer are aggressive diseases with grim prognoses. The long term survival of pancreatic carcinoma is still one of the worst of all cancers. Ninety-five percent of the patients die of their disease within 5 years [Wagener et al: Ann Oncol S(Supp1 3): S87-S90, 19941. Eighty-five percent of patients with jejunal carcinoma die of their disease within 5 years [Lioe, Biggart: J Clin Pathol43533-536, 19901. To date, there are disappointingly few effective cytotoxic agents in the treatment of these cancers.

We present a case of advanced-stage pancreatic carcinoma and a case of advanced stage jejunal carcinoma, each showing marked response to Taxol and platinum chemotherapy.